AGG-523

DRUG3 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

HealthyHealthy SubjectsOsteoarthritis

Phase 1

Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses in Healthy

CompletedNCT00380900

Wyeth is now a wholly owned subsidiary of PfizerHealthy Subjects, Osteoarthritis

Start: 2006-07-31End: 2007-02-28Updated: 2007-12-05

Study Evaluating AGG-523 in Subjects With Osteoarthritis

CompletedNCT00427687

Wyeth is now a wholly owned subsidiary of PfizerOsteoarthritis

Start: 2007-02-28End: 2007-06-30Updated: 2008-08-05

A Study of the Safety, Tolerability, and Pharmacokinetics of AGG-523 in Healthy Japanese Males

CompletedNCT00434785

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2007-02-28End: 2007-09-30Updated: 2007-12-05